Nonprofit Sues Celgene for Blocking Generic Competition By Sam | June 26, 2017 A new class-action lawsuit from a terminal blood cancer patient claims that Celgene abused consumer safety regulations to monopolize cancer drugs. Source: Drug Industry Daily Posted in Drug Industry Daily